North America Cancer Therapy Market
The North American cancer therapy market is expected to grow at a CAGR of XX% and reach USD XXmillion by 2022.Cancer is a malignant growth caused by uncontrolled division ofcells in a part of body. Cancer is the leading cause of death and the incidence rates are increasing annually. Due to this, demand for quality cancer treatments also has risen dramatically which is contributing to the growth of the market.
The end-users of this market are clinics, hospitals and research centers. Lung cancer, breast cancer, colorectal cancers, ovarian cancer, head and neck cancer, stomach cancer and liver cancer are some of the common cancers with increased treatment options in North America.
Rise in cancer incidence
Increasing access to modern therapeutics
Increasing geriatric population
Increase in innovations, improvements and approvals
The major restraints to the growth of the market are the high prices of therapy, change in reimbursement policies, and challenges faced in clinical trials.
The cancer therapy market is segmented based on therapy into targeted cancer therapy (hormone therapy, signal transduction inhibitors, gene expression modulators, apoptosis inducers, etc.), immunotherapy (monoclonal antibodies, cancer vaccines, non-specific immunotherapy), and chemotherapy. Based on geography, North America market is segmented into USA, Mexico and Canada.
Some of the key players in this market include –
Chugai Pharmaceutical Co., Ltd.
GPC Biotech AG
OSI Pharmaceuticals, Inc.
Market analysis for the North American cancer therapy market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market.
Identification and analysis of the macro and micro factors that affect the North American cancer therapy market.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is growing and to also identify the regions that are still untapped.